Secondary chemotherapy for high-risk gestational trophoblastic neoplasia
- 1 May 2005
- journal article
- review article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 97 (2), 618-623
- https://doi.org/10.1016/j.ygyno.2005.02.004
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy☆Gynecologic Oncology, 2003
- Treatment of gestational trophoblastic tumorsCurrent Treatment Options in Oncology, 2002
- Etoposide and Cisplatin/Etoposide, Methotrexate, and Actinomycin D (EMA) Chemotherapy for Patients With High-Risk Gestational Trophoblastic Tumors Refractory to EMA/Cyclophosphamide and Vincristine Chemotherapy and Patients Presenting With Metastatic Placental Site Trophoblastic TumorsJournal of Clinical Oncology, 2000
- Risk Factors for the Prediction of Treatment Failure in Gestational Trophoblastic Tumors Treated with EMA/CO RegimenGynecologic Oncology, 1998
- EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.Journal of Clinical Oncology, 1997
- Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapyAmerican Journal of Obstetrics and Gynecology, 1996
- Etoposide-Platin Combination Therapy for Chemorefractory Gestational Trophoblastic DiseaseGynecologic Oncology, 1995
- Single-agent methotrexate chemotherapy for the treatment of nonmetastatic gestational trophoblastic tumorsAmerican Journal of Obstetrics and Gynecology, 1995
- Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989BJOG: An International Journal of Obstetrics and Gynaecology, 1991
- Treatment of high-risk gestational trophoblastic disease with chemotherapy combinations containing cisplatin and etoposideCancer, 1989